Accessed:

(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium

4 of 4 defined stereocentres

Charge

Structural identifiers

Names and synonyms

[ACD/IUPAC Name]

(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium

[German]

[ACD/IUPAC Name]

(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(méthylsulfanyl)méthyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium

[French]

[ACD/IUPAC Name]

Pyrrolidinium, 2-(4,5-dihydro-4-oxo-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-3,4-dihydroxy-5-[(methylthio)methyl]-, (2S,3S,4R,5S)-

[ACD/Index Name]

(1S)-1-(0-DEAZAHYPOXANTHIN-9-YL)-1,4-DIDEOXY-1,4-IMINO-5-METHYLTHIO-D-RIBITOL, MT-IMMUCILLIN-H, MT-IMMH

3,4-DIHYDROXY-2-[(METHYLSULFANYL)METHYL]-5-(4-OXO-4,5-DIHYDRO-3H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)PYRROLIDINIUM

MTI

Database IDs